Our team has 100+ years of collective pharmaceutical industry experience, over 100 patents and applications covering a wide range of therapeutic targets and chemical classes.
Provid was co-founded in 2001 by Drs. Gary Olson, Christopher Self, and Charles Cook, together with Profs. Amos B. Smith, III and Ralph Hirschmann of the University of Pennsylvania. The team has exceptional talent in synthetic and medicinal chemistry and includes world leaders in peptide and peptide mimetics technology and in structure-based drug design. Their experience makes Provid the premier drug discovery company for early stage research and translational drug development.
